Despite strong revenue, Lifecome Biochemistry's growth rates...
Despite strong revenue, Lifecome Biochemistry's growth rates lag behind the industry's predicted 842% growth. Investors may face disappointment if P/S falls in line with recent growth rates. The company's poor three-year revenue trends aren't resulting in a lower P/S as expected. Without significant medium-term performance improvement, preventing P/S ratio decline will be challenging.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000001775adcbbdcdeb.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment